MedTrace Logo

Survey of Testosterone Levels in Male Cancer Patients

NCT00483418 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2011-03-11

No results posted yet for this study

Summary

The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and presence of opiate use for pain management, which is known to reduce testosterone levels.

Conditions

  • Hypogonadism

Sponsors & Collaborators

  • Solvay Pharmaceuticals

    collaborator INDUSTRY

  • St. Luke's-Roosevelt Hospital Center

    collaborator OTHER

  • Christiana Care Health Services

    collaborator OTHER

  • Beth Israel Medical Center

    lead OTHER

Principal Investigators

  • Stewart B Fleishman, MD · Continuum Cancer Centers of New York

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483418 on ClinicalTrials.gov